Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
AG Chapuis, SM Lee, JA Thompson… - Journal of Experimental …, 2016 - rupress.org
AG Chapuis, SM Lee, JA Thompson, IM Roberts, KA Margolin, S Bhatia, HL Sloan, I Lai…
Journal of Experimental Medicine, 2016•rupress.org© 2016 Chapuis et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the
publication date (see http://www. rupress. or g/terms). After six months it is available under a
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,
as described at http://creativecommons. org/licenses/by-nc-sa/3. 0/).
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the
publication date (see http://www. rupress. or g/terms). After six months it is available under a
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,
as described at http://creativecommons. org/licenses/by-nc-sa/3. 0/).
© 2016 Chapuis et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www. rupress. or g/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons. org/licenses/by-nc-sa/3. 0/).
rupress.org
